financetom
Forex World Market Business Cryptocurrency Commodities MAP
financetom
Business
financetom
/
Business
/
AstraZeneca Says Imfinzi Plus Chemotherapy Reduced Death Risk by 22% in Early Gastric Cancer Phase III Trial
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
AstraZeneca Says Imfinzi Plus Chemotherapy Reduced Death Risk by 22% in Early Gastric Cancer Phase III Trial
Oct 17, 2025 6:46 AM

09:04 AM EDT, 10/17/2025 (MT Newswires) -- AstraZeneca ( AZN ) said Friday that Imfinzi (durvalumab) and standard-of-care chemotherapy reduced the risk of death by 22% compared to chemotherapy alone in a phase III trial to treat early gastric cancer.

The company said that in the final overall survival analysis, an estimated 69% of patients treated with the Imfinzi-based regimen were alive at three years, compared with 62% for standard-of-care chemotherapy.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Goldman Sachs Insider Sold Shares Worth $6,910,421, According to a Recent SEC Filing
Goldman Sachs Insider Sold Shares Worth $6,910,421, According to a Recent SEC Filing
Jul 25, 2025
05:15 PM EDT, 07/25/2025 (MT Newswires) -- Denis P. Coleman, Chief Financial Officer, on July 25, 2025, sold 9,539 shares in Goldman Sachs ( GS ) for $6,910,421. Following the Form 4 filing with the SEC, Coleman has control over a total of 22,712 shares of the company, with 18,594 shares held directly and 4,118 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/886982/000190018825000010/xslF345X05/wk-form4_1753477587.xml...
 BRIEF-Strategy Files For Offering Of 28.0 Million Shares Of Variable Rate Series A Perpetual Stretch Preferred Stock - SEC Filing
BRIEF-Strategy Files For Offering Of 28.0 Million Shares Of Variable Rate Series A Perpetual Stretch Preferred Stock - SEC Filing
Jul 25, 2025
July 25 (Reuters) - Microstrategy Inc ( MSTR ): * STRATEGY FILES FOR OFFERING OF 28.0 MILLION SHARES OF VARIABLE RATE SERIES A PERPETUAL STRETCH PREFERRED STOCK - SEC FILING * STRATEGY SAYS STRETCH PREFERRED STOCK WILL HAVE STATED AMOUNT OF $100 PER SHARE AND INITIAL LIQUIDATION PREFERENCE OF $100 PER SHARE Source text: Further company coverage: ...
 Life360 Insider Sold Shares Worth $344,087, According to a Recent SEC Filing
Life360 Insider Sold Shares Worth $344,087, According to a Recent SEC Filing
Jul 25, 2025
05:18 PM EDT, 07/25/2025 (MT Newswires) -- Lauren Antonoff, Chief Operating Officer, on July 24, 2025, sold 4,546 shares in Life360 ( LIF ) for $344,087. Following the Form 4 filing with the SEC, Antonoff has control over a total of 307,778 shares of the company, with 307,778 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1581760/000158176025000166/xslF345X05/wk-form4_1753477836.xml ...
 Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
About
Terms and Conditions Privacy policy Cookie Settings Contact Us
Services
Login register
financetom Market Personal Finance Business Economy Cryptocurrency MAP
Links
zpostcode Recruit weather mreligion Yellowpages sport constellation shopping name game directory literature Word tour furnish Lottery tftnews lyrics News digital car dir Edu Finance
Copyright 2023-2026 - www.financetom.com All Rights Reserved